BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19728556)

  • 1. Specificity and clinical performance of two commercial TRACP 5b immunoassays.
    Ylipahkala H; Fagerlund KM; Janckila AJ; Houston B; Laurie D; Halleen JM
    Clin Lab; 2009; 55(5-6):223-8. PubMed ID: 19728556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment.
    Fagerlund KM; Janckila AJ; Ylipahkala H; Tiitinen SL; Nenonen A; Cheng S; Uusi-Rasi K; Yam LT; Väänänen HK; Halleen JM
    Clin Lab; 2008; 54(9-10):347-54. PubMed ID: 19097492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
    Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
    Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
    Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
    Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
    Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
    Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
    Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
    Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
    Halleen JM
    Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
    Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM
    J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
    Janckila AJ; Simons RM; Yam LT
    Clin Chim Acta; 2004 Sep; 347(1-2):157-67. PubMed ID: 15313154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
    Mose S; Menzel C; Kurth AA; Obert K; Breidert I; Borowsky K; Böttcher HD
    Anticancer Res; 2003; 23(3C):2783-8. PubMed ID: 12926113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay.
    Wu Y; Lee JW; Uy L; Abosaleem B; Gunn H; Ma M; DeSilva B
    J Pharm Biomed Anal; 2009 Jul; 49(5):1203-12. PubMed ID: 19356879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
    Rissanen JP; Suominen MI; Peng Z; Halleen JM
    Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Nakasato YR; Halleen JM; Hentunen T; Yam LT
    Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum.
    Nakanishi M; Yoh K; Miura T; Ohasi T; Rai SK; Uchida K
    Clin Chem; 2000 Apr; 46(4):469-73. PubMed ID: 10759470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
    Chao TY; Wu YY; Janckila AJ
    Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of serum TRACP in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Yam LT
    J Bone Miner Res; 2008 Aug; 23(8):1287-95. PubMed ID: 18410226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
    Janckila AJ; Parthasarathy RN; Parthasarathy LK; Seelan RS; Hsueh YC; Rissanen J; Alatalo SL; Halleen JM; Yam LT
    J Leukoc Biol; 2005 Feb; 77(2):209-18. PubMed ID: 15542543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium.
    Ylipahkala H; Halleen JM; Kaija H; Vihko P; Väänänen HK
    Biochem Biophys Res Commun; 2003 Aug; 308(2):320-4. PubMed ID: 12901871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
    Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
    Alatalo SL; Ivaska KK; Waguespack SG; Econs MJ; Väänänen HK; Halleen JM
    Clin Chem; 2004 May; 50(5):883-90. PubMed ID: 15016726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.